Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemia. [electronic resource]
Producer: 20060728Description: 208-10 p. digitalISSN:- 0141-9854
- Antineoplastic Agents -- adverse effects
- Benzamides
- Blast Crisis -- drug therapy
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Middle Aged
- Neutropenia -- chemically induced
- Piperazines -- adverse effects
- Pyrimidines -- adverse effects
- Recombinant Proteins
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.